Genetic Alterations of DLC1 in Medulloblastoma and Primitive Neuroectodermal Tumor

Qing Chang,Jesse C.S. Pang,Ho‐Keung Ng

IF: 11.2

2004-01-01

Cancer Research

Abstract:91 Medulloblastoma (MB) is the most common malignant embryonic tumor in childhood that arises from the posterior fossa of brain. Tumor with highly similar pathological features as MB but is found in other parts of the brain is referred to as primitive neuroectodermal tumor (PNET). Our group has previously demonstrated a high frequency of allelic loss on the short arm of chromosome 8 in MB and localized two critical regions of deletion that map to 8p21.3-22 and 8p23.1. These deletion regions are also noted as recurrent genetic aberrations in a variety of human tumors. Recently, a novel gene named DLC-1 is identified from 8p22 and its product shares high sequence homology with rat p122-RhoGAP. RhoGAP may function as tumor suppressor by down-regulating Rho activity, which is involved in Ras-mediated oncogenic transformation. Indeed, promotor hypermethylation, homozygous deletion and lack of expression of DLC-1 have been detected in liver, breast, colon, prostate and gastric cancers, indicating that this gene is involved in tumorigenesis. The aim of this study was to investigate whether DLC-1 played a role in the development of MB and PNET. We first evaluated the expression and methylation status in 26 microdissected MB, 4 MB cell lines, 4 microdissected PNET, one PNET cell line as well as 2 normal cerebellum and brain tissues. Reverse transcription-polymerase chain reaction analysis showed that DLC-1 was expressed in majority of tumors, all cell lines and normal tissues. One MB (case MB248) and 1 PNET(case AH312)were found not to express DLC-1. Promoter hypermethylation was detected in the PNET sample not expressing DLC-1, but such aberration was not seen in MB248. Duplex PCR analysis on MB248 revealed no homozygous deletion of the DLC-1 gene. We further screened for somatic mutation of all 14 exons using direct sequencing. One base substitution on exon 5 (800A>G, N267S) of DLC-1 was detected in MB248, which was later confirmed to be genetic polymorphism. Absence of DLC-1 expression in MB248 is probably regulated by other mechanism not examined in the current study. In conclusion, our molecular analyses of DLC-1 suggest that inactivation of this gene by promotor hypermethylation may play an important role in the tumorigenesis of PNET, but this result needs to be confirmed in a larger series.